News file for: Pancreatic Cancer
Scientists have tailor-made a new chemical compound that blocks a key cancer protein.
Researchers have found that patients carrying genetic mutations that characterize Lynch syndrome face an increased risk of developing breast and pancreatic cancer.
The Forgotten Cancers Project launched yesterday by the Cancer Council Victoria hopes to understand the causes of less common and under-researched cancers.
Davos Life Science announced today preliminary results of a Phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer.